ABSTRACT
GBS serotypes III and V were the most prevalent in pregnant women and exhibited resistance to tetracycline, clindamycin and sulfamethoxazole/trimethoprim. Serotype III showed high sialic acid content and PFGE analysis discerned 33 heterogeneous profiles. Phenotypic and genotypic characterization could be relevant to control GBS infections unaffected by intra-partum chemoprophylaxis.
Subject(s)
Female , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Serogroup , Streptococcal Infections/epidemiology , Streptococcus agalactiae/isolation & purification , Anti-Bacterial Agents/pharmacology , Brazil/epidemiology , Cluster Analysis , Drug Resistance, Bacterial , Electrophoresis, Gel, Pulsed-Field , Genotype , Molecular Typing , Prevalence , Pregnancy Complications, Infectious/microbiology , Streptococcal Infections/microbiology , Streptococcus agalactiae/classification , Streptococcus agalactiae/drug effectsABSTRACT
GBS serotypes III and V were the most prevalent in pregnant women and exhibited resistance to tetracycline, clindamycin and sulfamethoxazole/trimethoprim. Serotype III showed high sialic acid content and PFGE analysis discerned 33 heterogeneous profiles. Phenotypic and genotypic characterization could be relevant to control GBS infections unaffected by intra-partum chemoprophylaxis.
